Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sodium Acetazolamide
2. 1424-27-7
3. Acetazolamide Sodium Salt
4. Acetazolamide Sodium [jan]
5. Chebi:31163
6. N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide Monosodium Salt
7. 429zt169uh
8. Sodium;(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonylazanide
9. Diamox (tn)
10. Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-, Monosodium Salt
11. Acetazolamide Sodium (jan)
12. Schembl40813
13. Unii-429zt169uh
14. Chembl1200814
15. Dtxsid00162031
16. Acetazolamide Sodium [vandf]
17. Acetazolamide Sodium [mart.]
18. Acetazolamide Sodium [who-dd]
19. Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-, Monosodium Salt
20. Acetazolamide Sodium Salt [mi]
21. Acetazolamide Sodium [green Book]
22. Acetazolamide Sodium [orange Book]
23. D01196
24. Q27114185
25. Sodium [(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonyl]azanide
Molecular Weight | 244.2 g/mol |
---|---|
Molecular Formula | C4H5N4NaO3S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | 243.97007666 g/mol |
Monoisotopic Mass | 243.97007666 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 302 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Acetazolamide sodium |
PubMed Health | Acetazolamide sodium |
Active Ingredient | Acetazolamide sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Sagent Agila; X Gen Pharms; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Acetazolamide sodium |
PubMed Health | Acetazolamide sodium |
Active Ingredient | Acetazolamide sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Sagent Agila; X Gen Pharms; Eurohlth Intl |
Related Excipient Companies
Market Place
ABOUT THIS PAGE
A Acetazolamide Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acetazolamide Sodium, including repackagers and relabelers. The FDA regulates Acetazolamide Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acetazolamide Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acetazolamide Sodium supplier is an individual or a company that provides Acetazolamide Sodium active pharmaceutical ingredient (API) or Acetazolamide Sodium finished formulations upon request. The Acetazolamide Sodium suppliers may include Acetazolamide Sodium API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acetazolamide Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acetazolamide Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acetazolamide Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acetazolamide Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acetazolamide Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acetazolamide Sodium suppliers with NDC on PharmaCompass.
Acetazolamide Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acetazolamide Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acetazolamide Sodium GMP manufacturer or Acetazolamide Sodium GMP API supplier for your needs.
A Acetazolamide Sodium CoA (Certificate of Analysis) is a formal document that attests to Acetazolamide Sodium's compliance with Acetazolamide Sodium specifications and serves as a tool for batch-level quality control.
Acetazolamide Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Acetazolamide Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acetazolamide Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Acetazolamide Sodium EP), Acetazolamide Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acetazolamide Sodium USP).
LOOKING FOR A SUPPLIER?